Welcome to our dedicated page for QTREX Quantum Ltd. SEC filings (Ticker: QTEX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
QTREX Quantum Ltd. (QTEX) SEC filings document a foreign private issuer whose disclosures focus on Form 6-K current reports, registration statements, shareholder meetings, corporate articles and equity plan updates. The company’s filings show its Nasdaq symbol, Israeli base, Form 20-F reporting status and recurring use of Form 6-K to furnish press releases and material-event information.
For QTREX, the most relevant filing topics are closely tied to its AME and quantum computing infrastructure business. Recent 6-K reports have attached announcements on AME technology deployment, cryogenic quantum interconnect research, patent-pending materials work, RF performance qualification and research collaboration activity. These filings help investors trace the company’s disclosed progress in Additively Manufactured Electronics, quantum connectivity, defense-related programs and medical technology portfolio matters.
QTREX filings also include corporate governance and capital-structure records. The company has furnished shareholder meeting materials, voting results, amended and restated articles of association, registration statement information, Form F-1 clarification materials and equity incentive plan updates. These documents are important for understanding ordinary share authorization, shareholder approvals, compensation policy votes, registration obligations and securities reserved under equity plans.
Because QTREX is not described in its recent filings as a conventional domestic issuer, its core regulatory trail is built around Form 6-K event reports and Form 20-F status rather than the standard 10-Q and 10-K pattern used by many U.S. companies. Investors researching QTEX filings often focus on material agreements, shareholder voting matters, capital-structure disclosure and furnished press releases that describe the company’s AME platform and quantum infrastructure activities.
QTREX Quantum Ltd. (QTEX) announced that one of Israel’s three largest defense companies, described as a leading global aerospace and defense organization, has begun deploying QTREX’s Additively Manufactured Electronics (AME) technology in a joint development program focused on strategic, high‑precision systems. The first AME system is already being installed at the partner’s facilities.
The collaboration includes exclusivity provisions and a potential phased commercial pathway for broader AME system rollouts, with aggregate revenue for QTREX described as being in the tens of millions of dollars, subject to negotiation and execution of definitive agreements. The program centers on adapting QTREX’s proprietary AME platform through customized R&D, advanced materials and process optimization to meet demanding aerospace and defense requirements, with initial revenue from system deployment and recurring consumables and later phases potentially involving procurement of tailored AME systems. QTREX continues to position its AME and quantum connectivity solutions alongside its medical technology portfolio.
QTREX Quantum Ltd. (QTEX) reported that director Parnes Tal received a grant/award acquisition of 550,000 Ordinary Shares in the form of Restricted Share Units under the company’s 2019 Plan. After this award, Tal directly holds 760,000 Ordinary Shares, subject to a multi‑year vesting schedule.
The RSUs vest 33.34% on the first anniversary date following July 1, 2026, with the remaining 8.33% vesting quarterly over 8 quarters. The grant was approved by shareholders at an Extraordinary General Meeting on August 28, 2026.
QTREX Quantum Ltd. (symbol: QTEX) is the issuer of record for a Form 4 filing submitted to the SEC.
QTREX Quantum Ltd. (QTEX) reported that director Amit Lior received a grant of 170,000 Restricted Share Units (RSUs) on 2026-08-28, recorded as an acquisition of Ordinary Shares at a stated price of $0.0000 per share. Following this equity award, Lior’s direct holdings total 231,667 Ordinary Shares.
The RSUs were granted under QTREX Quantum Ltd.’s 2019 Plan. According to the vesting schedule, 33.34% of the RSUs vest on the first anniversary date following July 1, 2026, and the remaining RSUs vest at 8.33% per quarter over the next eight quarters. The RSU grant was approved by the company’s shareholders at an Extraordinary General Meeting of Shareholders held on 2026-08-28.
QTREX Quantum Ltd. (symbol: QTEX) is the issuer of record for a Form 4 filing submitted to the SEC.
QTREX Quantum Ltd. (QTEX) held its Annual and Extraordinary General Meeting of Shareholders on August 28, 2026, where a quorum was present and all agenda items were voted on by the required majority thresholds. Shareholders approved Proposal Nos. 1, 2 and 4 through 11, while Proposal No. 3, an updated compensation policy, did not receive the required approval. The company adopted Amended and Restated Articles of Association reflecting the approval of Proposal Nos. 10 and 11, which are attached as an exhibit. This report and its exhibits are incorporated by reference into QTREX Quantum Ltd.’s existing Form F-3 and Form S-8 registration statements filed with the SEC.
QTREX Quantum Ltd. (QTEX) received a Schedule 13G reporting that investment entities affiliated with Davidson Kempner beneficially own Ordinary Shares of the company. Davidson Kempner Capital Management LP and Anthony A. Yoseloff each report beneficial ownership of 5,030,000 Ordinary Shares, representing 7.50% of the outstanding class, with shared voting and dispositive power. Davidson Kempner Arbitrage, Equities and Relative Value LP reports 4,943,484 shares ( 7.37% ), and M.H. Davidson & Co. reports 86,516 shares ( 0.13% ), all with shared voting and dispositive power and no sole voting or dispositive power. The reported percentages are based on 67,075,045 Ordinary Shares outstanding as disclosed in a company prospectus filed on August 21, 2026.
QTREX Quantum Ltd. (symbol QTEX) is conducting a registered direct offering of 11,111,111 Ordinary Shares at $0.90 per share to certain institutional investors, for $10.0 million in gross proceeds. A.G.P./Alliance Global Partners is acting as exclusive placement agent on a reasonable best efforts basis and will receive a $0.063-per-share fee, or $700,000 in total.
QTREX expects net proceeds of about $9.1 million, to be used for working capital and general corporate purposes. Shares outstanding will increase from 55,963,934 to 67,075,045. The company reports a going concern explanatory paragraph in its 2025 financial statements and highlights significant dilution: pro forma as-adjusted net tangible book value would be $0.39 per share versus the $0.90 offering price, implying dilution of $0.51 per share, or 57%, for new investors. QTREX focuses on quantum computing connectivity and an additively manufactured electronics platform while retaining a legacy medical technology subsidiary it is seeking to monetize.
QTREX Quantum Ltd. (QTEX) entered into a Securities Purchase Agreement with institutional investors for a registered direct offering of 11,111,111 ordinary shares at $0.90 per share. The transaction is being conducted under the company’s effective shelf registration statement on Form F-3.
Gross proceeds to QTREX are expected to be about $10 million before fees and expenses. A.G.P./Alliance Global Partners is acting as exclusive placement agent and will receive a 7.0% cash fee, plus up to $50,000 in reimbursed expenses and $12,500 in non-accountable expenses. Closing is expected on or about August 21, 2026, subject to customary conditions.
The company agreed that for 30 days after closing it will not issue or agree to issue additional ordinary shares or equivalents, or file new registration statements, subject to specified exceptions. QTREX plans to use the net proceeds for working capital and general corporate purposes.
QTREX Quantum Ltd. (QTEX) announced a patent-pending technology that uses localized laser processing to directly convert 3D-printed dielectric insulation into electrically conductive, graphene-like carbon, creating patterned conductors without adding separate conductive materials or components. The company is integrating this into quantum packages as monolithic stray-photon absorbers aimed at protecting superconducting quantum processors from harmful radiation.
Research at Northeastern University, using QTREX’s AME platform and DF INSU300 material, produced conductive carbon across 20 laser-processing conditions, with Raman spectroscopy confirming the graphene-like structure. QTREX targets commercial launch of DF INSU300 by the end of the third quarter of 2026 and is validating performance at cryogenic temperatures and high frequencies while collaborating with quantum-computing partners on absorber applications and future integration with superconducting materials.